ADMA Biologics ADMA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $165.35M+12.5% | $146.93M-29.8% | $209.45M+0.2% | $208.93M+1.0% | $206.77M+4.6% | ||
| $7.8M-1.3% | $7.9M0.0% | $7.9M+1.3% | $7.8M+1.3% | $7.7M0.0% | ||
| $21.73M+8.5% | $20.03M-0.2% | $20.07M+10.3% | $18.2M+13.0% | $16.1M+18.2% | ||
| $128.32M+155% | $50.4M-22.4% | $64.97M-15.3% | $76.71M-24.2% | $101.22M-14.7% | ||
| $20.42M-9.6% | $22.58M-6.9% | $24.25M+122% | $10.94M+3.4% | $10.58M+28.6% | ||
| -$14.77M+32.5% | -$21.89M+10.2% | -$24.37M-120% | -$11.1M-1.5% | -$10.93M-27.5% | ||
| —— | —— | —— | —— | —— | ||
| -$47.07M-6.8% | -$44.07M+33.2% | -$65.98M-3.7% | -$63.62M+0.6% | -$63.98M-9.7% | ||
| —— | —— | —— | —— | $27.84M-47.8% | ||
| $107.9M+288% | $27.82M-31.7% | $40.73M-38.1% | $65.77M-27.4% | $90.64M-17.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does ADMA Biologics's cash flow data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.